The Value of the Van Nuys Prognostic Index in Ductal Carcinoma In Situ of the Breast: A Retrospective Analysis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Breast Journal

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1524-4741.2007.00443.xPMID 17593040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen receptor immunohistoohemistry in carcinoma in situ of the breast

  2010cited by this paper
• Breast-conserving therapy for ductal carcinoma in situ Bijker

  2008cited by this paper
• DCIS treatment varies across USA

  2004cited by this paper
• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.

  2003cited by this paper
• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

  2003cited by this paper
• The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast.

  2003cited by this paper
• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

  2003cited by this paper
• Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast

  2002cited by this paper
• Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

  2001cited by this paper
• Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.

  2001cited by this paper
• Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

  2001cited by this paper
• Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status.

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age

  2000cited by this paper
• The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy.

  2000cited by this paper
• Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.

  2000cited by this paper
• Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion?

  2000cited by this paper
• [Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17].

  1999cited by this paper
• The influence of margin width on local control of ductal carcinoma in situ of the breast.

  1999cited by this paper
• Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

  1999cited by this paper
• Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17

  1999cited by this paper
• Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma

  1999cited by this paper
• Predictors of local recurrence after treatment of ductal carcinoma in situ - A meta-analysis

  1999cited by this paper
• Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

  1998cited by this paper
• Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia.

  1998cited by this paper
• Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.

  1996cited by this paper
• A prognostic index for ductal carcinoma in situ of the breast

  1996cited by this paper
• Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.

  1996cited by this paper
• The Van Nuys Prognostic Index for Ductal Carcinoma In Situ

  1996cited by this paper
• Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications.

  1994cited by this paper
• Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast‐conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment

  1993cited by this paper
• Distribution of estrogen receptor in ductal carcinoma in situ of the breast.

  1993cited by this paper
• Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

  1993cited by this paper
• Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice

  1990cited by this paper
• Estrogen receptors in ductal carcinoma in situ of breast.

  1990cited by this paper
• Duct Carcinoma in Situ: Pathology and Treatment

  1990cited by this paper
• Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• [Carcinomas in situ of the breast].

  1981cited by this paper
• Noninvasive Breast Carcinoma: Results of a National Survey by the American College of Surgeons

  1980cited by this paper
• Preoperative localization of nonpalpable breast lesions demonstrated by mammography.

  1976cited by this paper

• Predictors and nomogram for upstaging to invasive breast carcinoma in ductal carcinoma in situ diagnosed by ultrasound-guided core needle biopsy

  2025cites this paper
• Tools to Guide Radiation Oncologists in the Management of DCIS

  2024cites this paper
• Quality of life issues in patients with ductal carcinoma in situ: a systematic review

  2024influential citation
• Risk Assessment in the Molecular Era.

  2022cites this paper
• Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low‐grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR)

  2022cites this paper
• The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ

  2020cites this paper
• Collagen (XI) alpha-1 chain (COL11A1) is an independent prognostic factor in breast ductal carcinoma in situ

  2019cites this paper
• Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies

  2019cites this paper
• Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ

  2019cites this paper
• Breast Specimen Processing and Reporting With an Emphasis on Margin Evaluation: A College of American Pathologists Survey of 866 Laboratories.

  2018cites this paper
• Phosphohistone 3 (PHH3) and lactate dehydrogenase 5 (LDH5) are expressed in ductal carcinoma in situ of the breast: possible clinical implications

  2017cites this paper
• Premalignant and Malignant Breast Pathology

  2016cites this paper
• Is anti-hormonal treatment in DCIS of the breast a need?

  2016cites this paper
• Diagnostic evaluation of ductal carcinoma in situ of the breast: ultrasonographic, mammographic and histopathologic correlations.

  2015cites this paper
• Clinicopathological significance of ‘atypical ductal proliferation’ in core needle biopsy of the breast

  2014cites this paper
• Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?

  2014cites this paper
• Current view on ductal carcinoma in situ and importance of the margin thresholds: A review

  2014cites this paper
• Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes

  2014cites this paper
• Narrowing down the focus: what are the main predictive markers for ductal carcinoma in situ?

  2014cites this paper
• Ductal carcinoma in situ.

  2013cites this paper
• Management of ductal carcinoma in situ according to Van Nuys Prognostic Index in Australia and New Zealand

  2012cites this paper
• Quantifying the extent of invasive carcinoma and margin status in partial mastectomy cases having a gross lesion: is a defined tissue processing protocol needed?

  2011cites this paper
• Fine Tuning of the Van Nuys Prognostic Index (VNPI) 2003 by Integrating the Genomic Grade Index (GGI): New Tools for Ductal Carcinoma In Situ (DCIS)

  2011cites this paper
• Can we know what to do when DCIS is diagnosed?

  2011cites this paper
• Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project

  2010cites this paper
• Duct Carcinoma In Situ: A Gordian Knot Untied

  2010cites this paper
• Protocol for the Examination of Specimens from Patients with Ductal Carcinoma In Situ ( DCIS ) of the Breast Protocol applies to DCIS without invasive carcinoma or microinvasion

  2010cites this paper
• Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

  2010cites this paper
• Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.

  2009cites this paper
• • Complete Excision (Less Than Total Mastectomy, Including Specimens Designated Biopsy, Lumpectomy, Quadrantectomy, and Partial Mastectomy; With or Without Axillary Contents) • Mastectomy (Total, Modified Radical, Radical; With or Without Axillary Contents)

  2009cites this paper
• Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma in situ in breast excision specimens.

  2009cites this paper
• Development of a Procedure for Genome-wide Expression Profiling from Minute Tissue Samples and Application in Mammary Carcinoma:Gene Activity Patterns Unveiling Molecular Pathways and Predicting Clinical Response

  2008cites this paper
• Why individualize breast cancer survivors' follow-up?

  2007cites this paper